Tarl W. Prow
- Pharmaceutical Science top 0.1%
- Advancements in Transdermal Drug Delivery 33
- Advanced Drug Delivery Systems 9
- Dermatology top 0.2%
- Skin Protection and Aging 20
- Dermatology and Skin Diseases 16
- Biophysics top 0.5%
- Advanced Fluorescence Microscopy Techniques 8
- Immunology top 5%
- Biomaterials top 5%
-
- Cutaneous Melanoma Detection and Management 25
-
- Nonmelanoma Skin Cancer Studies 14
-
- Advanced biosensing and bioanalysis techniques 9
- Co-authors
- Michael S. RobertsMiko YamadaH. Peter SoyerJeffrey E. GriceLynlee L. LinXianfeng ChenAnthony P. RaphaelM. A. F. Kendall
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)PLoS ONE (5 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Tarl W. Prow
122 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Pharmaceutical Science 1.5k
- Dermatology 1.2k
- Biophysics 353
- Immunology 518
- Biomaterials 301
Countries citing papers authored by Tarl W. Prow
This map shows the geographic impact of Tarl W. Prow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarl W. Prow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarl W. Prow more than expected).
Fields of papers citing papers by Tarl W. Prow
This network shows the impact of papers produced by Tarl W. Prow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarl W. Prow. The network helps show where Tarl W. Prow may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tarl W. Prow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 9 | |
| 5 | Health-related toxicity of emerging per- and polyfluoroalkyl substances: Comparison to legacy PFOS and PFOAbreakdown → | 2022 | 189 |
| 6 | 2021 | 25 | |
| 7 | 2018 | 19 | |
| 8 | 2016 | 12 | |
| 9 | 2016 | 38 | |
| 10 | 2015 | 10 | |
| 11 | 2015 | 8 | |
| 12 | 2015 | 13 | |
| 13 | 2014 | 71 | |
| 14 | Comparative analysis of UV-induced DNA damage and metabolic deterioration in skin by gamma-H2AX immunohistochemistry and NAD(P)H imaging | 2011 | 1 |
| 15 | Non-invasive assessment of skin ageing | 2011 | 2 |
| 16 | Nanoparticles and microparticles for skin drug deliverybreakdown → | 2011 | 610 |
| 17 | 2008 | 19 | |
| 18 | Characterization of Vascular Precursors in Developing Human Retina | 2007 | 2 |
| 19 | 2005 | 3 | |
| 20 | Development of a novel targeted nanoparticle gene therapy strategy for the treatment of hepatitis C virus infection | 2002 | 1 |
About Tarl W. Prow
Tarl W. Prow is a scholar working on Pharmaceutical Science, Dermatology and Biophysics, having authored 127 papers that have together received 4.5k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (33 papers), Cutaneous Melanoma Detection and Management (25 papers), Skin Protection and Aging (20 papers), Dermatology and Skin Diseases (16 papers), Nonmelanoma Skin Cancer Studies (14 papers), Advanced Drug Delivery Systems (9 papers), Advanced biosensing and bioanalysis techniques (9 papers) and Advanced Fluorescence Microscopy Techniques (8 papers). The work is most often cited by research in Pharmaceutical Science (1.5k citations), Dermatology (1.2k citations) and Biophysics (353 citations). Tarl W. Prow has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Michael S. Roberts, Miko Yamada, H. Peter Soyer, Jeffrey E. Grice, Lynlee L. Lin, Xianfeng Chen, Anthony P. Raphael, M. A. F. Kendall, Germain J. P. Fernando and Michael L. Crichton. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.